Loading provider…
Loading provider…
Rheumatology Physician in Cleveland, OH
NPI: 1235245622Primary Employer
Sbl Physician Billing
sarahbush.org
HQ Phone
Get M.D. Richard's Phone Numberphone_androidMobile
Get M.D. Richard's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
1993 - 2026
MN State Medical License
2021 - 2023
NM State Medical License
2021 - 2022
WI State Medical License
2013 - 2021
IA State Medical License
1987 - 1994
IL State Medical License

American Board of Internal Medicine
Internal Medicine
Boston University Medical Center
Fellowship • Rheumatology
1985 - 1987
Residency • Internal Medicine
1982 - 1985
University Of Michigan Medical School
medschool.umich.edu
Medical School
Until 1982
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99204New patient office or other outpatient visit, 45-59 minutes | 20 | 20 |
Glenohumeral osteoarthritis: frequency of underlying diagnoses and the role of arm dominance—a retrospective analysis in a community-based musculoskeletal practice
Authors: Theodore L. Schoenfeldt, Scott Trenhaile, Richard R. Olson
Publication Date: 2018-02
Acquired immunodeficiency syndrome-associated arthritis.
Authors: Richard I. Rynes, Don L. Goldenberg, Ralph A. Digiacomo, Richard R. Olson, Maleka Hussain, James M. Veazey
Publication Date: 1988-05
Methods for Developing the American College of Rheumatology's Electronic Clinical Quality Measures.
Authors: Murray Passo, Matthew Bunyard, Gabriela Schmajuk, Martin Bergman
Journal: Arthritis Care Res (Hoboken)
Publication Date: 2016-09-16
Lead Sponsor: Eli Lilly and Company
Collaborators: Incyte Corporation
Intervention / Treatment: DRUG: Placebo, DRUG: Baricitinib
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Baricitinib